KIF4A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.741350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.838200E-01
Normal-vs-Stage2
1.595820E-01
Normal-vs-Stage3
2.961400E-01
Normal-vs-Stage4
3.438000E-01
Stage1-vs-Stage2
3.241000E-01
Stage1-vs-Stage3
7.981000E-01
Stage1-vs-Stage4
7.711800E-01
Stage2-vs-Stage3
5.671600E-01
Stage2-vs-Stage4
6.055000E-01
Stage3-vs-Stage4
9.615400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.839430E-01
Normal-vs-AfricanAmerican
2.274800E-01
Normal-vs-Asian
5.558000E-02
Caucasian-vs-AfricanAmerican
7.157800E-01
Caucasian-vs-Asian
6.673600E-01
AfricanAmerican-vs-Asian
8.164000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.305780E-01
Normal-vs-Female
2.178400E-01
Male-vs-Female
5.570800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.197200E-01
Normal-vs-Age(41-60Yrs)
2.104000E-01
Normal-vs-Age(61-80Yrs)
1.257580E-01
Normal-vs-Age(81-100Yrs)
1.164610E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.892400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.029400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.525600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.175760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.659800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.715400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.407200E-01
Normal-vs-Daily Drinker
1.289990E-01
Normal-vs-Weekly Drinker
3.258800E-01
Normal-vs-Occasional Drinker
1.203950E-01
Normal-vs-Social Drinker
1.910590E-01
Non Drinker-vs-Daily Drinker
8.678600E-01
Non Drinker-vs-Weekly Drinker
4.263600E-01
Non Drinker-vs-Occasional Drinker
5.914800E-01
Non Drinker-vs-Social Drinker
9.510000E-01
Daily Drinker-vs-Weekly Drinker
3.760400E-01
Daily Drinker-vs-Occasional Drinker
4.381800E-01
Daily Drinker-vs-Social Drinker
8.178600E-01
Weekly Drinker-vs-Occasional Drinker
6.097200E-01
Weekly Drinker-vs-Social Drinker
4.580000E-01
Occasional Drinker-vs-Social Drinker
6.624600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.576200E-01
Normal-vs-Grade 2
5.971600E-01
Normal-vs-Grade 3
6.203800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.183400E-03
Grade 1-vs-Grade 3
3.562000E-04
Grade 1-vs-Grade 4
5.576200E-01
Grade 2-vs-Grade 3
1.138810E-01
Grade 2-vs-Grade 4
5.971600E-01
Grade 3-vs-Grade 4
6.203800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.293000E-01
Normal-vs-NonDiabetic
1.754950E-01
Diabetic-vs-NonDiabetic
1.076240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.980300E-03
Normal-vs-NoPancreatitis
2.176800E-01
Pancreatitis-vs-NoPancreatitis
1.664610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.914200E-02
Normal-vs-N1
1.844430E-01
N0-vs-N1
3.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.637500E-02
Normal-vs-TP53-NonMutant
1.962200E-01
TP53-Mutant-vs-TP53-NonMutant
1.5539600000003E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
